These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2905797)

  • 21. Efficacy of kava-kava in the treatment of non-psychotic anxiety, following pretreatment with benzodiazepines.
    Malsch U; Kieser M
    Psychopharmacology (Berl); 2001 Sep; 157(3):277-83. PubMed ID: 11605083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Practical aspects of the clinical management of benzodiazepine dependence].
    Moodley P; Araya R
    Rev Med Chil; 1988 May; 116(5):472-5. PubMed ID: 2907671
    [No Abstract]   [Full Text] [Related]  

  • 23. Propranolol in chronic liver disease: a controlled trial of its effect and safety over twelve months.
    Hayes PC; Crichton S; Shepherd AN; Bouchier IA
    Q J Med; 1987 Oct; 65(246):823-34. PubMed ID: 3329738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alprazolam as an adjunct to propranolol in anxious outpatients with stable angina pectoris.
    Mendels J; Chernoff RW; Blatt M
    J Clin Psychiatry; 1986 Jan; 47(1):8-11. PubMed ID: 3510196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of extended-release benzodiazepines in the treatment of anxiety: a risk-benefit evaluation with a focus on extended-release alprazolam.
    Klein E
    J Clin Psychiatry; 2002; 63 Suppl 14():27-33. PubMed ID: 12562116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta blockade after myocardial infarction: the Norwegian propranolol study in high-risk patients.
    Hansteen V
    Circulation; 1983 Jun; 67(6 Pt 2):I57-60. PubMed ID: 6342841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
    Lydiard RB; Ballenger JC; Rickels K
    J Clin Psychiatry; 1997; 58 Suppl 11():11-8. PubMed ID: 9363043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Symptom severity and quality of life after benzodiazepine withdrawal treatment in participants with complicated dependence.
    Vorma H; Naukkarinen H; Sarna S; Kuoppasalmi K
    Addict Behav; 2004 Aug; 29(6):1059-65. PubMed ID: 15236807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative trial of Tenormin (atenolol) and Inderal (propranolol) in migraine.
    Stensrud P; Sjaastad O
    Ups J Med Sci Suppl; 1980; 31():37-40. PubMed ID: 7006182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Double-blind evaluation of the safety and hypnotic efficacy of lormetazepam in general practice.
    Moja EA; Scamonatti L; Maxia D; Camera A; Gherardi S
    Clin Ther; 1983; 5(6):580-4. PubMed ID: 6138152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benzodiazepine dependence: a shadowy diagnosis.
    Tyrer P
    Biochem Soc Symp; 1993; 59():107-19. PubMed ID: 7910738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Benzodiazepine withdrawal with carbamazepine].
    Kaendler SH; Volk S; Pflug B
    Nervenarzt; 1996 May; 67(5):381-6. PubMed ID: 9005346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double blind cross-over clinical trial of acebutolol and propranolol in angina pectoris.
    Pandhi P; Sethi V; Sharma BK; Wahi PL; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):598-600. PubMed ID: 3908331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-dose dependence in chronic benzodiazepine users: a preliminary report on 119 patients.
    Rickels K; Case WG; Schweizer EE; Swenson C; Fridman RB
    Psychopharmacol Bull; 1986; 22(2):407-15. PubMed ID: 2877472
    [No Abstract]   [Full Text] [Related]  

  • 35. Benzodiazepine withdrawal symptoms and propranolol.
    Tyrer P; Rutherford D; Huggett T
    Lancet; 1981 Mar; 1(8219):520-2. PubMed ID: 6111632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reactivating addiction-related memories under propranolol to reduce craving: A pilot randomized controlled trial.
    Lonergan M; Saumier D; Tremblay J; Kieffer B; Brown TG; Brunet A
    J Behav Ther Exp Psychiatry; 2016 Mar; 50():245-9. PubMed ID: 26454715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Propranolol in the treatment of anxiety.
    Suzman MM
    Postgrad Med J; 1976; 52 Suppl 4():168-74. PubMed ID: 787957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of propranolol for cocaine dependence treatment may depend on cocaine withdrawal symptom severity.
    Kampman KM; Volpicelli JR; Mulvaney F; Alterman AI; Cornish J; Gariti P; Cnaan A; Poole S; Muller E; Acosta T; Luce D; O'Brien C
    Drug Alcohol Depend; 2001 Jun; 63(1):69-78. PubMed ID: 11297832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of propranolol in opiate dependence.
    Resnick RB; Kestenbaum RS; Schwartz LK; Smith A
    Arch Gen Psychiatry; 1976 Aug; 33(8):993-7. PubMed ID: 60091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benzodiazepine dependent patients and their psychological treatment.
    Crouch G; Robson M; Hallstrom C
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(4):503-10. PubMed ID: 2900539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.